Adhera Therapeutics Inc (ATRX)

[Threeflight]

MRNA reasons for potential $25 stock>

1. This stock was above $3 early this year back when it was strictly a nasal company. They have plenty of cash still left and no real debt. And an OS of ONLY 31 Million. That is amazing to me that they havent diluted.
2. They now have a ceo who was solely responsible for the Merck buyout of RNAI for $1.1 billion last year. He has since moved on to MRNA as CEO and we are just now beginning to see the results of his efforts. Expect a ton more to come in the very near future.
3. The have a CSO coming in Jan 2 that was in charge or research at Merck and RNAI. That means connections.
4. They have RNAi patents that could be worth billions in the next few years. They have many more patents than RNAI ever did and look what happened with that :).
5. The FDA approval today allows them to stay on the Nasdaq, partner up with major phrama if need be, and it brings in 10's of millions of dollars a year. That means revs to fund RNAi development WITHOUT diluting or financing.

RNAi is a field that most Doctors say will be the way to cure disease by 2012 or so. It has a potential market in the $100's of billions if not trillions. MRNA is by far the leading publicly traded stock in this field. If RNAI got bought out for $1.1 billion almost 2 years ago, what does that make MRNA worth 2 years from now when their patents are that much closer to actually being used to cure disease? Even $1.1 Billion divided by a 31 M OS is over $36/share.

IMO the potential is here for a hundred dollar stock or higher in 2-3 years. We shall see.